Advances in AI-based diagnosis of Alzheimer’s disease using MRI: a comprehensive survey - Scorecard - MDSpire

Advances in AI-based diagnosis of Alzheimer’s disease using MRI: a comprehensive survey

  • By

  • Hasan Issa Raheem Alyaqoobi

  • Jose Manuel Lopez-Guede

  • Omer Asghar Dara

  • Jose Antonio Ramos-Hernanz

  • Iñigo Aramendia

  • Daniel Teso-Fz-Betoño

  • June 1, 2026

  • 0 min

Share

Clinical Scorecard: Progress in AI-Driven MRI Diagnostics for Alzheimer’s Disease: An In-Depth Review

At a Glance

CategoryDetail
Condition
Key MechanismsRevise to reflect current understanding of neurodegeneration and MRI capabilities.
Target Population
Care Setting

Key Highlights

  • add_examples

Guideline-Based Recommendations

Diagnosis

    Management

    • S
    • u
    • g
    • g
    • e
    • s
    • t
    • a
    • d
    • d
    • i
    • t
    • i
    • o
    • n
    • a
    • l
    • m
    • a
    • n
    • a
    • g
    • e
    • m
    • e
    • n
    • t
    • s
    • t
    • r
    • a
    • t
    • e
    • g
    • i
    • e
    • s
    • b
    • e
    • y
    • o
    • n
    • d
    • A
    • I
    • f
    • r
    • a
    • m
    • e
    • w
    • o
    • r
    • k
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Detail how early diagnosis can lead to improved treatment outcomes.

        Clinical Best Practices

        • standardization

        Related Resources & Content

        Original Source(s)

        Advances in AI-based diagnosis of Alzheimer’s disease using MRI: a comprehensive survey

        • by Hasan Issa Raheem Alyaqoobi, Jose Manuel Lopez-Guede, Omer Asghar Dara, Jose Antonio Ramos-Hernanz, Iñigo Aramendia, Daniel Teso-Fz-Betoño

        • June 1, 2026

        Related Content

        Editorial: Unraveling protein misfolding and innate immunity in neurodegenerative diseases

        Neuroinflammation in Alzheimer’s disease: glial crosstalk, pathological modulation, and therapeutic implications

        Late-life difficult-to-treat depression and dementia subtypes: a naturalistic cohort study using electronic health records